Advanced Oncotherapy (AVO)

Sector:

Health Care

 1.93p
   
  • Change Today:
      0.000p
  • 52 Week High: 25.00
  • 52 Week Low: 1.75
  • Currency: UK Pounds
  • Shares Issued: 542.57m
  • Volume: 0
  • Market Cap: £10.44m

Advanced Oncotherapy draws down first $10m from Nerano facility

By Josh White

Date: Friday 21 Aug 2020

LONDON (ShareCast) - (Sharecast News) - Proton cancer treatment developer Advanced Oncotherapy has drawn down an initial $10m (£7.65m) from the interest-bearing secured convertible facility with Nerano Pharma, it announced on Friday.
The AIM-traded firm had announced details of the facility on 29 June.

"In relation to the first draw down of this facility, the company has as a result paid a commitment fee of $0.6m to Nerano Pharma," the board said in its statement.

"The funds drawn down will be used to further the development of the company's LIGHT system."

At 1608 BST, shares in Advanced Oncotherapy were up 0.31% at 32.6p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AVO Market Data

Currency UK Pounds
Share Price 1.93p
Change Today 0.000p
% Change 0.00 %
52 Week High 25.00
52 Week Low 1.75
Volume 0
Shares Issued 542.57m
Market Cap £10.44m

AVO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
59.89% below the market average59.89% below the market average59.89% below the market average59.89% below the market average59.89% below the market average
29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average
Income Not Available
Growth Not Available

AVO Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

AVO Key Personnel

CEO Nicolas Serandour

Top of Page